Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 trial evaluating bevacizumab, temozolomide, and external beam radiotherapy as first-line therapy for newly diagnosed glioblastoma mu…
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab [Phase 2]
Phase 2 clinical trial evaluating oral pazopanib plus oral topotecan given in a metronomic antiangiogenic regimen for recurrent glioblastoma…
-
CLINICAL_TRIALS trial_result · 2020-08-06Clinical Trial Update: Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients [Phase 1, Phase 2]
Phase 1/2 study of enzastaurin in newly diagnosed glioblastoma multiforme and gliosarcoma completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Sirolimus in Treating Patients With Glioblastoma Multiforme [Phase 1, Phase 2]
Clinical trial update for sirolimus in patients with glioblastoma multiforme spanning Phase 1 and Phase 2, completed.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: A Phase 1b/2, Multicenter, Open-label Study of ACP-196 in Subjects With Recurrent Glioblastoma Multiforme (GBM) [Phase 1, Phase 2]
Clinical trial update for ACP-196 (acalabrutinib) in recurrent glioblastoma multiforme, a phase 1b/2 open-label study; the trial status is a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 trial evaluating bortezomib, temozolomide, and regional radiation therapy for newly diagnosed glioblastoma multiforme or gliosarcoma…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]
Clinical trial update for VB-111 in recurrent glioblastoma multiforme (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM) [Phase 3]
Phase 3 trial update for ADCTA as adjuvant immunotherapy in recurrent glioblastoma multiforme undergoing standard treatment.
-
CLINICAL_TRIALS trial_result · 2020-03-12Clinical Trial Update: A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 [Phase 2]
Phase 2 trial update for autologous heat shock protein gp96 immunotherapy in glioma of the brain (glioblastoma context not explicitly stated…
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma [Phase 3]
Phase 3 trial comparing hyperfractionated radiotherapy with BCNU to conventional radiotherapy with BCNU in supratentorial malignant glioma.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: FET-PET for Evaluation of Response of Recurrent GBM to Avastin [Phase 2]
Phase 2 trial evaluating FET-PET to assess response of recurrent glioblastoma to Avastin has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-10Clinical Trial Update: Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating hydroxychloroquine combined with radiation and temozolomide for newly diagnosed glioblastoma multiforme; st…
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma [Phase 2]
Phase 2 study evaluating TRC105 in combination with bevacizumab in glioblastoma completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-12Clinical Trial Update: Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide [NA]
A completed clinical trial evaluating neural progenitor cell-sparing radiation therapy in combination with temozolomide for glioblastoma mul…
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors [Phase 2]
Phase 2 clinical trial update for tumor lysate-pulsed dendritic cell immunotherapy in patients with glioblastoma.
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating border zone stereotactic radiosurgery with bevacizumab in glioblastoma multiforme has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer [Phase 2]
Phase 2 clinical trial update for V-Boost immunotherapy in glioblastoma multiforme; status and results are currently unknown.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) [Phase 2]
Phase 2 trial update for cilengitide in recurrent glioblastoma multiforme.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme [Phase 2]
A Phase 2 clinical trial evaluated hypofractionated IMRT with temozolomide and bevacizumab for glioblastoma multiforme; study status complet…
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme
A completed clinical trial evaluating whether [11C]-Methionine PET/MRI can tailor postoperative radiochemotherapy for glioblastoma multiform…
-
CLINICAL_TRIALS trial_result · 2018-11-29Clinical Trial Update: Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients [Phase 2, Phase 3]
Clinical trials investigating chlorogenic acid for injection for safety and efficacy in Grade IV glioblastoma multiforme (GBM) patients, spa…
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial investigating temozolomide with SCH66336 for recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma [Phase 2]
Phase 2 trial evaluating bevacizumab and erlotinib after radiation and temozolomide in newly diagnosed glioblastoma multiforme or gliosarcom…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating aminolevulinic acid (5-ALA) for fluorescence-guided visualization of glioblastoma tumors during surgical resection …
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: GW572016 to Treat Recurrent Malignant Brain Tumors [Phase 2]
Phase 2 trial of GW572016 (lapatinib) for recurrent malignant brain tumors has completed.